Literature DB >> 10368698

Interferon plus ribavirin for chronic hepatitis C.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10368698

Source DB:  PubMed          Journal:  Med Lett Drugs Ther        ISSN： 0025-732X            Impact factor:   1.909


× No keyword cloud information.
  2 in total

Review 1.  Hepatitis C: cost of illness and considerations for the economic evaluation of antiviral therapies.

Authors:  John B Wong
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

2.  Analysis of sequence configurations of the ISDR, PKR-binding domain, and V3 region as predictors of response to induction interferon-alpha and ribavirin therapy in chronic hepatitis C infection.

Authors:  Melissa D Murphy; Hugo R Rosen; Gail I Marousek; Sunwen Chou
Journal:  Dig Dis Sci       Date:  2002-06       Impact factor: 3.199
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.